Lead Product(s) : Lincomycin Hydrochloride
Therapeutic Area : Immunology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
Details : H021 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Colitis, Ulcerative.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 04, 2024
Lead Product(s) : Lincomycin Hydrochloride
Therapeutic Area : Immunology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lincomycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule
Details : Lincomycin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Bacterial Infections.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
January 29, 2010
Lead Product(s) : Lincomycin Hydrochloride
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
